title: Does boceprevir really increase the risk of skin eruptions during antihepatitis C treatment?
authors.affiliation: Department of Dermatology, Hospital Universitario La Princesa, Diego de León 62, 28006, Madrid, Spain. rachel170786@gmail.com.
authors.forename: R
authors.initials: R
authors.lastname: Carrascosa
authors.affiliation: Department of Dermatology, Hospital Universitario La Princesa, Diego de León 62, 28006, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Llamas-Velasco
authors.affiliation: Department of Dermatology, Hospital Universitario La Princesa, Diego de León 62, 28006, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Montes-Torres
authors.affiliation: Department of Dermatology, Hospital Universitario La Princesa, Diego de León 62, 28006, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Sánchez-Pérez
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects*; D011392:Proline / Q000031:analogs & derivatives*; D011480:Protease Inhibitors / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011480:Protease Inhibitors; D011392:Proline